COVID-19 Updates
NMDOH Logo
Home News NMDOH highlights guidance for immunocompromised patients and booster doses of COVID-19 vaccine for special populations

NMDOH highlights guidance for immunocompromised patients and booster doses of COVID-19 vaccine for special populations

February 23, 2022 - 2019 Novel Coronavirus - Awareness

SANTA FE - The New Mexico Department of Health (NMDOH) today announced an enhanced COVID-19 tool kit for a subset of immunocompromised New Mexicans. Among the updated recommendations are increased access to treatments, continued mask wearing, and an additional booster vaccine for severely immunocompromised individuals, transplant recipients, and those in active cancer treatment.

“Hospitalizations and case counts are down, but we need to be mindful of those in our communities at higher risk for severe outcomes associated with COVID-19, including the immunocompromised and those with chronic illnesses,'' said Acting NMDOH Cabinet Secretary David R. Scrase, M.D. “We demonstrate our support by recommending additional boosters to those eligible, increasing access to treatments, and calling on all New Mexicans to respect that many will continue to wear masks indoors.”

The Centers for Disease Control and Prevention (CDC) initially suggested an additional dose for the more vulnerable population earlier this year, after determining the protective value of the vaccine against emerging variants. The recommendation that moderately to severely immunocompromised individuals receive a COVID-19 booster dose is further specified by the CDC here : Guidance for COVID-19 vaccination for people who are moderately or severely immunocompromised .

Individuals are considered to be moderately or severely immunocompromised if one or more of the following is true:
They are receiving active chemotherapy or radiation for tumors or blood cancers
They have received an organ transplant and are taking anti-rejection medication
They have received a stem cell transplant within the last two years
They have a primary immunodeficiency syndrome such as DiGeorge syndrome or Wiskott-Aldrich syndrome
They have advanced or untreated HIV
They are taking high dose corticosteroids, e.g., more than 20 mg of prednisone each day or medicines like methotrexate for rheumatoid arthritis
Some other immune-suppressing medications may qualify; individuals should talk to their doctor or call the COVID-19 hotline at  (press option 3) to determine if their medications qualify them for a fourth dose

In addition to boosters, there are COVID-19 treatments which can offer substitute antibodies to restore, enhance or mimic the immune system's attack on pathogens. Evusheld is a new, long-acting monoclonal antibody therapy that is widely available for immunocompromised individuals such as cancer patients and transplant recipients. More information on Evusheld can be found here: COVID-19 Preventive Medications .

NMDOH also encourages all New Mexicans to order free at-home COVID-19 tests to have on hand in case of exposure. Getting a fast COVID-19 diagnosis offers individuals the opportunity to seek immediate treatment, such as at-home oral treatments, within a critical 5-day window. To locate tests for delivery or pick up, visit:Find a COVID-19 Test in New Mexico
.

Another critical tool to offer protection to vulnerable New Mexicans is the continued use of well-fitting, high quality masks. NMDOH recommends and supports the use of masks for all those who are immunocompromised, have chronic health illnesses, and their caregivers. KN95 and N95 masks will provide the most protection, and are available at retail pharmacies and community health centers across New Mexico, for free while supplies last.

For more details on NMDOH recommendations for very vulnerable and/or severely immunocompromised New Mexicans, please visit:https://cv.nmhealth.org/extra-protection/

For more information about CDC vaccine guidance for these individuals, please visit: https://www.cdc.gov/coronavirus/2019-ncov/vaccines/recommendations/immuno.html


Media Contact

We would be happy to provide additional information about this press release. Simply contact Renee Narvaiz at (Office) with your questions.


Versión en Español

En un esfuerzo para hacer que nuestros comunicados de prensa sean más accesibles, también tenemos disponibles una versión en español. Por favor presione el enlace de abajo para acceder a la traducción.

El NMDOH resalta la orientacion para pacientes inmunocomprometidos y las dosis de refuerzo de la vacuna COVID-19 para grupos especiales de poblacion